Gene therapy startup Passage Bio raises $110M Series B, its second raise in less than a year
September 04, 2019 at 15:21 PM EDT
Passage Bio is the brainchild of University of Pennsylvania professor James Wilson.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|